These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37925627)

  • 1. Do people with eczema and their carers understand topical steroid potency? Results of two surveys.
    Moss C; Haider Z; Proctor A
    Clin Exp Dermatol; 2024 Feb; 49(3):267-270. PubMed ID: 37925627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carers' views of topical corticosteroid use in childhood eczema: a qualitative study of online discussion forums.
    Teasdale EJ; Muller I; Santer M
    Br J Dermatol; 2017 Jun; 176(6):1500-1507. PubMed ID: 27753076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis.
    Beattie PE; Lewis-Jones MS
    Clin Exp Dermatol; 2003 Sep; 28(5):549-53. PubMed ID: 12950351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of topical corticosteroids in pregnancy.
    Chi CC; Wang SH; Wojnarowska F; Kirtschig G; Davies E; Bennett C
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007346. PubMed ID: 26497573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions to reduce Staphylococcus aureus in the management of eczema.
    George SM; Karanovic S; Harrison DA; Rani A; Birnie AJ; Bath-Hextall FJ; Ravenscroft JC; Williams HC
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation.
    Green C; Colquitt JL; Kirby J; Davidson P; Payne E
    Health Technol Assess; 2004 Nov; 8(47):iii,iv, 1-120. PubMed ID: 15527669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid exposure and cumulative effects in patients with eczema: Results from a patient survey.
    Barta K; Fonacier LS; Hart M; Lio P; Tullos K; Sheary B; Winders TA
    Ann Allergy Asthma Immunol; 2023 Jan; 130(1):93-99.e10. PubMed ID: 36191848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.
    Garside R; Stein K; Castelnuovo E; Pitt M; Ashcroft D; Dimmock P; Payne L
    Health Technol Assess; 2005 Jul; 9(29):iii, xi-xiii,1-230. PubMed ID: 16022804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. #corticophobia: a review on online misinformation related to topical steroids.
    Finnegan P; Murphy M; O'Connor C
    Clin Exp Dermatol; 2023 Feb; 48(2):112-115. PubMed ID: 36730502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical corticosteroid phobia in adolescents with eczema and caregivers of children and adolescents with eczema: A cross-sectional survey.
    Tangthanapalakul A; Chantawarangul K; Wananukul S; Tempark T; Chatproedprai S
    Pediatr Dermatol; 2023 Jan; 40(1):135-138. PubMed ID: 36400426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical treatments for scalp psoriasis.
    Schlager JG; Rosumeck S; Werner RN; Jacobs A; Schmitt J; Schlager C; Nast A
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD009687. PubMed ID: 26915340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of topical corticosteroids in atopic eczema: an umbrella review.
    Axon E; Chalmers JR; Santer M; Ridd MJ; Lawton S; Langan SM; Grindlay DJC; Muller I; Roberts A; Ahmed A; Williams HC; Thomas KS
    BMJ Open; 2021 Jul; 11(7):e046476. PubMed ID: 34233978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the atrophogenic potential of topical corticosteroids in pediatric dermatology patients.
    Hong E; Smith S; Fischer G
    Pediatr Dermatol; 2011; 28(4):393-6. PubMed ID: 21507057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use.
    Green C; Colquitt JL; Kirby J; Davidson P
    Br J Dermatol; 2005 Jan; 152(1):130-41. PubMed ID: 15656813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agreement and Correlation Between Different Topical Corticosteroid Potency Classification Systems.
    Bowie AC; Tadrous M; Egeberg A; Harvey J; Lax SJ; Thyssen JP; Drucker AM
    JAMA Dermatol; 2022 Jul; 158(7):796-800. PubMed ID: 35612864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses.
    Hajar T; Leshem YA; Hanifin JM; Nedorost ST; Lio PA; Paller AS; Block J; Simpson EL;
    J Am Acad Dermatol; 2015 Mar; 72(3):541-549.e2. PubMed ID: 25592622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial.
    Sigurgeirsson B; Boznanski A; Todd G; Vertruyen A; Schuttelaar ML; Zhu X; Schauer U; Qaqundah P; Poulin Y; Kristjansson S; von Berg A; Nieto A; Boguniewicz M; Paller AS; Dakovic R; Ring J; Luger T
    Pediatrics; 2015 Apr; 135(4):597-606. PubMed ID: 25802354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement.
    Mooney E; Rademaker M; Dailey R; Daniel BS; Drummond C; Fischer G; Foster R; Grills C; Halbert A; Hill S; King E; Leins E; Morgan V; Phillips RJ; Relic J; Rodrigues M; Scardamaglia L; Smith S; Su J; Wargon O; Orchard D
    Australas J Dermatol; 2015 Nov; 56(4):241-51. PubMed ID: 25752907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unveiling the potential: Enhancing caregiver knowledge through video education to address topical corticosteroid concerns in children with eczematous dermatitis.
    Sitthisan M; Wananukul S; Chatproedprai S; Tempark T; Chantawarangul K
    Pediatr Dermatol; 2024; 41(2):221-228. PubMed ID: 38126606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.